Physician profile
Neil Patel
NPI 1154842425
$4,944.78
in general payments reported to CMS, 2019-2025
6 companies · $21.64 in 2025
The $21.64 reported for 2025 was less than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $117 · 2021: $49.28 · 2023: $4,476 · 2024: $281 · 2025: $21.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $2,500 · Food and Beverage: $904 · Education: $767 · Travel and Lodging: $607.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $2,500.00 |
| Food and Beverage | $904.31 |
| Education | $766.92 |
| Travel and Lodging | $607.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,816.29 | 2023-2024 | Synchromedii, Vanta Adaptivestim, Intellis Adaptivestim |
| Nevro Corp. | $844.11 | 2023 | Omnia, Senza |
| Medline Industries LP | $116.79 | 2019 | |
| Spr Therapeutics, INC | $96.67 | 2023-2024 | Sprint Pns System |
| Acera Surgical, INC. | $49.28 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $21.64 | 2025 | Exparel, Zilretta, Iovera |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neil Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.